Febuxostat Accord

Febuxostat Accord is a medication used to manage certain types of gout. It works by reducing uric acid levels in the body, helping to prevent gout attacks. This oral medication is manufactured by Accord Healthcare Limited.

Febuxostat is primarily used to lower uric acid levels in individuals with gout. Gout is a form of arthritis caused by excess uric acid in the bloodstream, leading to painful joint inflammation. Febuxostat helps to prevent gout attacks by reducing the production of uric acid, making it a key treatment option for long-term management of this condition.

Common effects of Febuxostat may include nausea, diarrhea, and rash. Some individuals might experience liver function abnormalities or mild gastrointestinal discomfort. It is important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Febuxostat should be used with caution in individuals with liver or kidney problems. It is essential to follow the prescribed dosage and avoid sudden changes in medication without medical advice. Regular monitoring of liver function may be recommended during treatment.

Febuxostat may interact with certain medications, including azathioprine, mercaptopurine, and theophylline. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated, as it may affect liver function.